Detalhe da pesquisa
1.
RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.
Gene Ther
; 30(9): 706-713, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173386
2.
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.
J Transl Med
; 19(1): 265, 2021 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154602
3.
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.
Curr Res Transl Med
; 71(2): 103385, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773434
4.
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
J Immunother Cancer
; 10(7)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803613
5.
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch.
Cancer Gene Ther
; 28(12): 1365-1375, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414517
6.
Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro.
Immunol Res
; 71(2): 276-282, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456721
7.
[IL-1RAP as a candidate for CAR T-cells immunotherapy]. / IL-1RAP, un candidat pour l'immunothérapie par CAR T-cells.
Med Sci (Paris)
; 35(6-7): 497-500, 2019.
Artigo
em Francês
| MEDLINE | ID: mdl-31274074